Safety of COVID-19 Pfizer-BioNtech (BNT162b2) mRNA vaccination in adolescents aged 12–17 years: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Safety of COVID-19 Pfizer-BioNtech (BNT162b2) mRNA vaccination in adolescents aged 12–17 years: A systematic review and meta-analysis

Published:2022-11-11 Issue:6 Volume:18 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Katoto Patrick D. M. C.¹²³,Brand Amanda S.⁴,Byamungu Liliane N.⁵,Tamuzi Jacques L.²,Mahwire Tamirirashe C.²,Kitenge Marcel K.²,Wiysonge Charles S.⁶⁷,Gray Glenda¹

Affiliation:

1. Office of the President and CEO, South African Medical Research Council, Cape Town, South Africa

2. Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa

3. Centre for Tropical Diseases and Global Health, Department of Medicine, Catholic University of Bukavu, Bukavu, DR Congo

4. Centre for Evidence-based Health Care, Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa

5. Department of Pediatric, Faculty of Medicine and Health Sciences, University of KwaZulu-Natal, Durban, South Africa

6. Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa

7. HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa

Funder

funding associated with the work featured in this article

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2022.2144039

Reference55 articles.

1. Considering the impact of COVID-19 on children [Internet]. [accessed 2022 Jun 19]. https://www.who.int/europe/activities/considering-the-impact-of-covid-19-on-children

2. COVID-19 and children [Internet]. UNICEF DATA. [accessed 2022 Jun 19]. https://data.unicef.org/covid-19-and-children/

3. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2

4. Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study

5. Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 Vaccine Perspective From Adolescents’ Lens in the US;Cureus;2024-02-04

2. Anaphylaxis rates following mRNA COVID-19 vaccination in children and adolescents: Analysis of data reported to EudraVigilance;Vaccine;2023-03

3. Safety and immunogenicity of SCB-2019, an adjuvanted, recombinant SARS-CoV-2 trimeric S-protein subunit COVID-19 vaccine in healthy 12–17 year-old adolescents;2023-02-26

4. Effectiveness of COVID-19 Pfizer-BioNTech (BNT162b2) mRNA vaccination in adolescents aged 12–17 years: A systematic review and meta-analysis;Human Vaccines & Immunotherapeutics;2023-01-02

5. Safety and immunogenicity of SCB-2019, an adjuvanted, recombinant SARS-CoV-2 trimeric S-protein subunit COVID-19 vaccine in healthy 12–17 year-old adolescents;Human Vaccines & Immunotherapeutics;2023-01-02